Related Experiment Video

Updated: Jul 13, 2026

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
06:32

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone

JuanJuan Yin1, Claire Pollock, Kirsten Tracy

  • 1Cell and Cancer Biology Branch, Center for Cancer Research, National Cancer Institute, 37 Convent Dr., Rm. 1068, Bethesda, MD 20892, USA.

Molecular and Cellular Biology
|August 22, 2007
PubMed

Insights

Activated Ras signaling promotes prostate cancer metastasis to specific organs. The RalGEF pathway drives bone metastasis, while the Raf/ERK pathway aids brain metastasis, offering new therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Metastasis Research

Background:

  • Metastasis, a hallmark of cancer, exhibits organ specificity, yet the underlying signaling pathways remain poorly understood.
  • Tyrosine kinase receptor activation is often linked to prostate cancer progression.
  • Activated Ras, a common signaling intermediary, plays a crucial role in cancer cell signaling.

Purpose of the Study:

  • To investigate the role of activated Ras and its downstream effector pathways in prostate cancer metastasis.
  • To identify specific signaling pathways responsible for organ-specific colonization and growth of prostate cancer cells.

Main Methods:

  • Assayed three Ras effector pathways: Raf/extracellular signal-regulated kinase (ERK), phosphatidylinositol 3-kinase, and Ral guanine nucleotide exchange factors (RalGEFs).
  • Utilized a tumorigenic, nonmetastatic human prostate cancer cell line (DU145) and a metastatic cell line (PC3).
  • Examined the impact of oncogenic Ras and Ral pathway modulation on metastasis to various organs, including bone and brain.

Main Results:

  • Oncogenic Ras promoted metastasis of DU145 cells to bone and brain.
  • Activation of the Raf/ERK pathway specifically stimulated brain metastasis.
  • Activation of the RalGEF pathway led to bone metastases, the most common site for prostate cancer spread.
  • Loss of RalA in PC3 cells inhibited bone metastasis but not subcutaneous tumor growth, suggesting a role in expansive bone growth rather than initial homing.

Conclusions:

  • Ras effector pathways play distinct roles in organ-specific prostate cancer metastasis.
  • The RalGEF pathway is critical for the development of bone metastases, a key clinical challenge in prostate cancer.
  • These findings elucidate the functional significance of the Ral pathway in metastasis and identify potential targets for therapeutic intervention.

More Related Videos

RhoC GTPase Activation Assay09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

An Orthotopic Murine Model of Human Prostate Cancer Metastasis06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...